Generation of Prostate Tumor-Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling

被引:58
|
作者
Qu, Yi [1 ]
Oyan, Anne Margrete [1 ,4 ]
Liu, Runhui [8 ]
Hua, Yaping [1 ,8 ]
Zhang, Jigang [8 ]
Hovland, Randi [6 ]
Popa, Mihaela [7 ]
Liu, Xiaojun [1 ,8 ]
Brokstad, Karl A. [2 ]
Simon, Ronald [9 ]
Molven, Anders [1 ,5 ]
Lin, Biaoyang [10 ,11 ,12 ]
Zhang, Wei-dong [8 ]
McCormack, Emmet [3 ]
Kalland, Karl-Henning [1 ,4 ]
Ke, Xi-Song [1 ]
机构
[1] Univ Bergen, Gade Inst, Bergen, Norway
[2] Univ Bergen, Broegelmann Res Lab, Dept Clin Sci, Bergen, Norway
[3] Univ Bergen, Dept Med, Bergen, Norway
[4] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway
[5] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway
[6] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway
[7] KinN Therapeut AS, Bergen, Norway
[8] Second Mil Med Univ, Coll Pharm, Shanghai, Peoples R China
[9] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany
[10] Zhejiang Univ, Zhejiang Calif Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China
[11] Swedish Med Ctr, Seattle, WA USA
[12] Univ Washington, Dept Urol, Seattle, WA 98195 USA
关键词
CANCER STEM-CELL; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; IN-VITRO; MALIGNANT-TRANSFORMATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SELF-RENEWAL; ACTIVATION; INTERLEUKIN-6;
D O I
10.1158/0008-5472.CAN-13-1560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
How prostate cancer is initiated remains a topic of debate. In an effort to establish a human model of prostate carcinogenesis, we adapted premalignant human prostate EPT2-D5 cells to protein-free medium to generate numerous tight prostate spheres (D5HS) in monolayer culture. In contrast to EPT2-D5 cells, the newly generated D5HS efficiently formed large subcutaneous tumors and subsequent metastases in vivo, showing the tumorigenicity of D5HS spheres. A striking production of interleukin (IL)-6 mRNA and protein was found in D5HS cells. The essential roles of IL-6 and the downstream STAT3 signaling in D5HS tumor sphere formation were confirmed by neutralizing antibody, chemical inhibitors, and fluorescent pathway reporter. In addition, elevated reactive oxygen species (ROS) produced upon protein depletion was required for the activation of IL-6/STAT3 in D5HS. Importantly, a positive feedback loop was found between ROS and IL-6 during tumor sphere formation. The association of ROS/IL-6/STAT3 to the carcinogenesis of human prostate cells was further examined in xenograft tumors and verified by limiting dilution implantations. Collectively, we have for the first time established human prostate tumor-initiating cells based on physiologic adaption. The intrinsic association of ROS and IL-6/STAT3 signaling in human prostate carcinogenesis shed new light on this relationship and define therapeutic targets in this setting. (C)2013 AACR.
引用
收藏
页码:7090 / 7100
页数:11
相关论文
共 50 条
  • [31] Tumor-associated macrophages promote migration and invasion via modulating IL-6/STAT3 signaling in renal cell carcinoma
    Chen, Shaojun
    Qian, Subo
    Zhang, Lin
    Pan, Xiuwu
    Qu, Fajun
    Yu, Yongjiang
    Gu, Zhengqin
    Cui, Xingang
    Shen, Haibo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [32] IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
    Daniel Meraviglia-Crivelli
    Helena Villanueva
    Angelina Zheleva
    María Villalba-Esparza
    Beatriz Moreno
    Ashwathi Puravankara Menon
    Alfonso Calvo
    Javier Cebollero
    Martin Barainka
    Igor Ruiz de los Mozos
    Carlos Huesa-Berral
    Fernando Pastor
    Molecular Cancer, 21
  • [33] IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
    Meraviglia-Crivelli, Daniel
    Villanueva, Helena
    Zheleva, Angelina
    Villalba-Esparza, Maria
    Moreno, Beatriz
    Menon, Ashwathi Puravankara
    Calvo, Alfonso
    Cebollero, Javier
    Barainka, Martin
    de los Mozos, Igor Ruiz
    Huesa-Berral, Carlos
    Pastor, Fernando
    MOLECULAR CANCER, 2022, 21 (01)
  • [34] A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus
    Yadav, A.
    Kumar, B.
    Lang, J. C.
    Teknos, T. N.
    Kumar, P.
    ONCOGENE, 2017, 36 (46) : 6374 - 6382
  • [35] Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
    Neo, Shi Yong
    Tong, Le
    Chong, Joni
    Liu, Yaxuan
    Jing, Xu
    Oliveira, Mariana M. S.
    Chen, Yi
    Chen, Ziqing
    Lee, Keene
    Burduli, Nutsa
    Chen, Xinsong
    Gao, Juan
    Ma, Ran
    Lim, Jia Pei
    Huo, Jianxin
    Xu, Shengli
    Alici, Evren
    Wickstrom, Stina L.
    Haglund, Felix
    Hartman, Johan
    Wagner, Arnika K.
    Cao, Yihai
    Kiessling, Rolf
    Lam, Kong Peng
    Westerberg, Lisa S.
    Lundqvist, Andreas
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (747)
  • [36] A muscle-specific protein ‘myoferlin’ modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus
    A Yadav
    B Kumar
    J C Lang
    T N Teknos
    P Kumar
    Oncogene, 2017, 36 : 6374 - 6382
  • [37] Magnolol inhibits cancer stemness and IL-6/ Stat3 signaling in oral carcinomas
    Peng, Chih-Yu
    Yu, Cheng-Chia
    Huang, Chun-Chung
    Liao, Yi-Wen
    Hsieh, Pei-Ling
    Chu, Pei-Ming
    Yu, Chuan-Hang
    Lin, Shih-Shen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 51 - 57
  • [38] Stat3/IL-6 signaling mediates sustained pneumonia induced by Agiostrongylus cantonensis
    Zhou, Hongli
    Lu, Yuting
    Wei, Hang
    Chen, Yixin
    Limpanon, Yanin
    Dekumyoy, Paron
    Huang, Ping
    Shi, Peiyao
    Lv, Zhiyue
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (05):
  • [39] IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
    Manore, Sara G.
    Doheny, Daniel L.
    Wong, Grace L.
    Lo, Hui-Wen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients
    Cacciapaglia, Fabio
    Perniola, Simone
    Stano, Stefano
    Venerito, Vincenzo
    Natuzzi, Dorotea
    Bizzoca, Rita
    Iannone, Florenzo
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2025, 141